Spineology Gains De Novo Grant for OptiMesh Expandable Interbody Fusion

Spineology OptiLIF

Spineology was granted de novo classification from FDA for the OptiMesh® expandable spinal interbody fusion system. The grant follows successful completion of the SCOUT (Spineology Clinical Outcomes Trial) Investigational Device Exemption trial, which revealed substantial improvements in low back pain and function scores at 6, 12 and 24...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us